Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide

Clinical trial NCT04221529 · COMPLETED

Trial details

NCT number: NCT04221529
Sponsor: AIO-Studien-gGmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

SCLC, Extensive Stage

Start date: 2020-01-06
Primary completion: 2024-04-12
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.